• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STAAR SURGICAL COMPANY EVO/EVO+VISIAN IMPLANTABLE COLLAMER LENS; PHAKIC INTRAOCULAR LENS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STAAR SURGICAL COMPANY EVO/EVO+VISIAN IMPLANTABLE COLLAMER LENS; PHAKIC INTRAOCULAR LENS Back to Search Results
Model Number VICM5 12.6 (-07.50 )
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Hypopyon (1913); Blurred Vision (2137); Toxic Anterior Segment Syndrome (TASS) (4469)
Date of Event 02/24/2025
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
H6: type of investigation: 4110, lens work order search: no similar complaint type events reported for units within the same lot.H6: type of investigation 3331, device history record (dhr) review: based on the results of the investigation, all released devices from the associated work order(s), including the suspected device, have been manufactured within established process parameters and there is no indication that the manufacturing and processing of the device contributed to the complaint issue.H11: manufacturer narrative: tass toxic anterior segment syndrome (tass) is an acute sterile postoperative inflammation that can occur after uncomplicated or complicated intraocular surgery.While improper sterilization and contamination of surgical instruments remains the most common risk factor associated with tass, ocular viscoelastic, and improper preparation of antibiotics for intracameral injection may also lead to tass.An exact cause could not be determined as the event could be multifactorial in nature including patient and/or procedure related factors.H11: manufacture narrative: hypopyon is identified in the labeling as a known potential adverse event following icl implantation.Claim #: (b)(4).
 
Event or Problem Description
A facility representative reported that following an implantable collamer lens (icl) implantation procedure the patient experienced toxic anterior segment syndrome (tass) and hypopyon, diagnostic culture not performed.The treatment performed: steroid eye drops/ oral medication.Lens remains implanted and the problem was not resolved.Patient has the blurred vision and now under observation.Replacement lens surgery is scheduled to take place once the patient's eye has stabilized.Cause of the event was reported as unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVO/EVO+VISIAN IMPLANTABLE COLLAMER LENS
Common Device Name
PHAKIC INTRAOCULAR LENS
Manufacturer (Section D)
STAAR SURGICAL COMPANY
1911 walker avenue
monrovia CA 91016
Manufacturer (Section G)
STAAR SURGICAL COMPANY
1911 walker avenue
monrovia CA 91016
Manufacturer Contact
joselene muniz
1911 walker avenue
monrovia, CA 91016
MDR Report Key21912339
Report Number2023826-2025-00616
Device Sequence Number12546683
Product Code MTA
UDI-Device Identifier00840311300556
UDI-Public(01)00840311300556(11)240807(17)270731
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
P030016
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2025
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Company Representative,Distributor
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 04/25/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberVICM5 12.6 (-07.50 )
Device Catalogue NumberVICM5 12.6
Device Lot NumberN/A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 04/01/2025
Initial Report FDA Received Date04/25/2025
Date Device Manufactured08/07/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient Age26 YR
Patient SexFemale
-
-